Related Experiment Video
Updated: Jan 16, 2026
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Comparative Analysis of Outcomes of Influenza and COVID-19 Admissions Among Children With Asthma: A Nationwide
Ying-Chen Chen1,2, Chia-Pi Cheng3, Po-Cheng Chen4
1Department of Pediatrics, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
Insights
Children with asthma hospitalized for COVID-19 face higher risks of sepsis and 90-day readmission, while influenza increases bacterial pneumonia risk. Different clinical approaches are needed based on infection type and age.
Area of Science:
- Pediatric Respiratory Medicine
- Infectious Diseases
- Epidemiology
Background:
- Childhood asthma prevalence is rising, increasing vulnerability to respiratory infections like COVID-19 and influenza.
- These infections can lead to severe complications, hospitalizations, and emergency care in children with asthma.
- Limited research compares in-hospital outcomes for pediatric asthma patients with COVID-19 versus influenza.
Purpose of the Study:
- To compare in-hospital outcomes for children with asthma hospitalized for COVID-19 versus influenza.
- To analyze outcomes from a population-based perspective using national health data.
Main Methods:
- A retrospective cohort study utilized the 2020 US Nationwide Readmissions Database.
- Included were 1472 children (1-19 years) with asthma admitted for COVID-19 or influenza.
- Outcomes assessed: in-hospital mortality, major complications, and 90-day readmission, analyzed via weighted logistic regression.
Main Results:
- Children with asthma hospitalized for COVID-19 had higher risks of sepsis/shock (aOR 4.30) but lower risks of bacterial/fungal pneumonia (aOR 0.37) than influenza patients.
- Younger children (1-5 years) with asthma hospitalized for COVID-19 showed a higher 90-day readmission risk (aOR 3.02).
- No significant difference in in-hospital mortality was found between COVID-19 and influenza groups.
Conclusions:
- COVID-19 hospitalization in children with asthma is linked to increased sepsis/shock risk, whereas influenza is associated with higher bacterial/fungal pneumonia risk.
- Children aged 1-5 with asthma hospitalized for COVID-19 face a greater risk of 90-day readmission.
- Tailored clinical management strategies are suggested for pediatric asthma patients based on the specific respiratory infection and patient age.
Background:
Asthma is a common chronic respiratory disease with increasing prevalence among children over the past few decades. It can cause significant respiratory symptoms and acute exacerbations, often requiring emergency care or hospitalization. Moreover, exposure to respiratory viral infections, such as COVID-19 and influenza, can trigger severe complications in children with asthma. Despite these concerns, few studies have directly compared the in-hospital outcomes of children with asthma experiencing these infections.
Objective:
This study aimed to compare the in-hospital outcomes of these infections in children with asthma from a population-based perspective.
Methods:
We conducted a population-based retrospective cohort study using data from the 2020 US Nationwide Readmissions Database. Children aged 1 to 19 years with asthma who were admitted for COVID-19 or influenza were eligible for inclusion. Outcomes evaluated included in-hospital mortality, major complications, and 90-day readmission rate. Survey-weighted logistic regression models were used to compare clinical outcomes between the two infection groups, adjusting for demographic and clinical characteristics.
Results:
A total of 1472 hospitalized children with asthma were included, of whom 405 (27.5%) were admitted for COVID-19 and 1067 (72.5%) for influenza. After adjustment, the multivariate analysis revealed that children admitted for COVID-19 had a significantly higher risk of sepsis or shock (adjusted odds ratio [aOR] 4.30, 95% CI 1.79-10.32) but a lower risk of bacterial or fungal pneumonia (aOR 0.37, 95% CI 0.23-0.61) compared with those admitted for influenza. Stratified analyses by age revealed that among children aged 1 to 5 years, the risk of 90-day readmission was significantly higher for those with COVID-19 than for those with influenza (aOR 3.02, 95% CI 1.09-8.35). No significant difference in in-hospital mortality was detected between the two infection groups in either the multivariable model or any of the age-stratified analyses.
Conclusions:
US children with asthma hospitalized for COVID-19 had higher risks of sepsis or shock compared to those admitted for influenza. In contrast, children admitted for influenza had a higher risk for bacterial or fungal pneumonia. After stratifying by age, children aged 1 to 5 years with COVID-19 had a significantly higher risk of 90-day readmission than those with influenza. Our findings suggest that different clinical approaches may be needed for children with asthma, depending on infection etiology and patient age.
More Related Videos
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
First, in...